A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients

Wendt, Ralph; Thijs, Lutgarde; Kalbitz, Sven; Mischak, Harald; Siwy, Justyna; Raad, Julia; Metzger, Jochen; Neuhaus, Barbara; Leyen, Heiko von der; Dudoignon, Emmanuel; Mebazaa, Alexandre; Spasovski, Goce; Milenkova, Mimoza; Canevska Taneska, Aleksandra; Czerwieńska, Beata; Wiecek, Andrzej; Peters, Björn; Nilsson, Åsa; Schwab, Matthias; Rothfuss, Katja

doi:10.1016/j.eclinm.2021.100883

A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients

Journal

EClinicalMedicine

Date Issued

2021-06

Author(s)

Wendt, Ralph

Thijs, Lutgarde

Kalbitz, Sven

Mischak, Harald

Siwy, Justyna

Raad, Julia

Metzger, Jochen

Neuhaus, Barbara

Leyen, Heiko von der

Dudoignon, Emmanuel

Mebazaa, Alexandre

Milenkova, Mimoza

Czerwieńska, Beata

Wiecek, Andrzej

Peters, Björn

Nilsson, Åsa

Schwab, Matthias

Rothfuss, Katja

Lübbert, Christoph

Staessen, Jan A

Beige, Joachim

DOI

10.1016/j.eclinm.2021.100883

Abstract

COVID-19 prediction models based on clinical characteristics, routine biochemistry and imaging, have been developed, but little is known on proteomic markers reflecting the molecular pathophysiology of disease progression.